New drug approvals hit 21-year high in 2017
U.S. drug approvals hit a 21-year high in 2017, with 46 novel medicines winning a green light -- more than double the previous year -- while the figure also rose in the European Union.
Tuesday, January 2, 2018
New drug approvals hit 21-year high in 2017
New drug approvals hit 21-year high in 2017
U.S. drug approvals hit a 21-year high in 2017, with 46 novel medicines winning a green light -- more than double the previous year -- while the figure also rose in the European Union.
Related Posts:
FTC, AT&T settle 2014 lawsuit over data slowdowns: court- Deutsche Bank to transfer up to 800 people to BNP in prime brokerage deal: source
- Explainer: What tools could Trump use to get U.S. firms to quit China?
- Wall Street Weekahead: Investors look at dollar stores as U.S. recession fears increase
- Factbox: From phone makers to farmers, the toll of Trump's trade wars
0 comments:
Post a Comment